Held on 26 September 2014
Chemo Pharma Laboratories announced that the Board of Directors of the Company at its meeting held on 26 September 2014, inter alia, took the following decisions:1. Approved the Resignation of Ashok Joshi from the position of Compliance Officer, Chief Financial Officer and Directorship of the Company.
2. Took on record the consent letter of Shanta Somani and appointed as Additional Director of the Company.
3. Appointed Darsh Mehta as Compliance Officer of the Company.
4. Considered Change in Position of Ashok Somani from the designation of Chief Executive Officer of the Company and appointed him as Chief Financial Officer of the Company.
5. Appointed Shanta Somani as Chief Executive Officer of the Company.
6. Considered and Approved Whistle Blower Policy and Vigil Mechanism of the Company along with the appointment of Balkishan Lohia as Group Ethics Officer of the Policy.
Powered by Capital Market - Live News
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app